Clinical trial
Effect of One-week vs Two-week Discontinuation of Methotrexate on Efficacy of Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial
NCT05069714 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of One-week vs Two-week Discontinuation of Methotrexate on Efficacy of Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 1, 2021
- Completion date
- September 30, 2022
- Enrollment
- 184 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune diseases, influenza, rheumatoid arthritis, vaccine reaction